Communication Intervention for Cancer Planning
Trial Summary
What is the purpose of this trial?
This trial tests whether Planning for Your Advance Care Needs (PLAN) intervention works to enhance Latino patients' understanding of and engagement in advanced care planning. The PLAN intervention may be an effective method to help people with cancer plan for and talk about advance care planning (the care they would want if they were unable to communicate) with their loved ones and doctors.
Will I have to stop taking my current medications?
The trial information does not specify whether you need to stop taking your current medications.
What data supports the effectiveness of the treatment Planning for Your Advance Care Needs (PLAN) for cancer patients?
Research shows that advance care planning, which involves discussing and recording patient preferences for future care, can improve communication between patients and doctors, especially at the end of life. Educating people about advance care planning has been effective in encouraging them to start important conversations and make necessary preparations.12345
Is the Communication Intervention for Cancer Planning safe for humans?
How is the treatment 'Planning for Your Advance Care Needs' different from other treatments for cancer planning?
Research Team
Megan J Shen, PhD.
Principal Investigator
Fred Hutch/University of Washington Cancer Consortium
Eligibility Criteria
This trial is for Latino adults with advanced or metastatic cancer who have had at least one round of chemotherapy. They must be able to give informed consent and speak English or Spanish fluently. It's not suitable for those severely cognitively impaired, too ill to interview, currently in hospice care, under 18, or deemed unsuitable by their oncologist.Inclusion Criteria
Exclusion Criteria
Trial Timeline
Screening
Participants are screened for eligibility to participate in the trial
Treatment
Participants in Arm I receive the PLAN intervention, consisting of 3 coaching sessions over 45-60 minutes each with a health coach. Arm II participants receive usual care.
Follow-up
Participants are monitored for changes in engagement, self-efficacy, completion of advance directives, feasibility, acceptability, knowledge, and readiness/motivation in advance care planning.
Treatment Details
Interventions
- Planning for Your Advance Care Needs (PLAN) (Behavioral Intervention)
Find a Clinic Near You
Who Is Running the Clinical Trial?
Weill Medical College of Cornell University
Lead Sponsor
Dr. Robert Min
Weill Medical College of Cornell University
Chief Executive Officer since 2024
MD, MBA
Dr. Adam R. Stracher
Weill Medical College of Cornell University
Chief Medical Officer since 2024
MD
Fred Hutchinson Cancer Center
Lead Sponsor
Dr. W. Thomas Purcell
Fred Hutchinson Cancer Center
Chief Medical Officer since 2022
MD from Emory University School of Medicine, MBA from University of Chicago
Dr. Thomas J. Lynch Jr.
Fred Hutchinson Cancer Center
Chief Executive Officer since 2020
MD from Yale School of Medicine
National Cancer Institute (NCI)
Collaborator
Dr. Douglas R. Lowy
National Cancer Institute (NCI)
Chief Executive Officer since 2023
MD from New York University School of Medicine
Dr. Monica Bertagnolli
National Cancer Institute (NCI)
Chief Medical Officer since 2022
MD from Harvard Medical School